Matthew Emmens Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew Emmens.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Emmens. Matthew Emmens is Director in BRISTOL MYERS SQUIBB CO ($BMY) and Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and President in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and President & CEO in VERTEX PHARMACEUTICALS INC / MA ($VRTX).
Matthew Emmens in VERTEX PHARMACEUTICALS INC / MA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew Emmens: President & CEO, President, Director
Holdings: 229,406 shares
Current Value: $19,921,617
Latest Transaction: Feb 07 2011
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Matthew Emmens in VERTEX PHARMACEUTICALS INC / MA
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Option Exercise | A | 38.80 | 236,000 | 9,156,800 | 236,000 | |
| Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Grant | A | 0.01 | 47,201 | 472 | 229,406 | 182.2 K to 229.4 K (+25.91 %) |
| Jul 16 2010 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Option Exercise | A | 33.82 | 118,000 | 3,990,760 | 118,000 | |
| Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Option Exercise | A | 39.05 | 354,000 | 13,823,700 | 354,000 | |
| Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Grant | A | 0.01 | 47,201 | 472 | 182,205 | 135 K to 182.2 K (+34.96 %) |
| Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President | Option Exercise | A | 33.55 | 549,000 | 18,418,950 | 549,000 | |
| Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President | Grant | A | 0.01 | 134,129 | 1,341 | 134,129 | 0 to 134.1 K |
| Jun 02 2008 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Director | Option Exercise | A | 28.40 | 20,000 | 568,000 | 20,000 | |
| Jun 04 2007 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Director | Option Exercise | A | 29.84 | 20,000 | 596,800 | 20,000 | |
| Jun 02 2006 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Director | Option Exercise | A | 34.32 | 20,000 | 686,400 | 50,000 | |
| Jun 03 2005 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Director | Option Exercise | A | 13.32 | 10,000 | 133,200 | 30,000 |
Page: 1